Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.30
11.80
(0.88%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddy's recalls Rivastigmine Tartrate Capsules from the US market
>>
Dr Reddys Laboratories submits copy of newspaper advertisement
>>
Dr. Reddys Laboratories trades in the green on BSE
>>
Dr. Reddy’s gains on launching PRAMIPEXOLE Dihydrochloride extended-release tablets in US
>>
Dr. Reddy’s launches PRAMIPEXOLE Dihydrochloride extended-release tablets in US
>>
Dr Reddys Laboratories informs about Press Release
>>
Dr. Reddy’s soars on entering into strategic collaboration with Amgen
>>
Dr. Reddy’s enters into strategic collaboration with Amgen
>>
Dr Reddys Laboratories informs about voting results of AGM
>>
Dr Reddy’s signs MoU with Purdue University for drug research and development
<<
<
108
109
110
...145
>
>>